nodes	percent_of_prediction	percent_of_DWPC	metapath
Amphetamine—Speech disorder—Hyoscyamine—pancreatitis	0.0223	0.0404	CcSEcCtD
Amphetamine—Erectile dysfunction—Propantheline—pancreatitis	0.0217	0.0393	CcSEcCtD
Amphetamine—Muscle twitching—Hyoscyamine—pancreatitis	0.0196	0.0354	CcSEcCtD
Amphetamine—Blood pressure increased—Hyoscyamine—pancreatitis	0.0192	0.0348	CcSEcCtD
Amphetamine—Tension—Propantheline—pancreatitis	0.0161	0.0291	CcSEcCtD
Amphetamine—Nervousness—Propantheline—pancreatitis	0.0159	0.0288	CcSEcCtD
Amphetamine—Palpitations—Propantheline—pancreatitis	0.0145	0.0262	CcSEcCtD
Amphetamine—Dry mouth—Propantheline—pancreatitis	0.0137	0.0247	CcSEcCtD
Amphetamine—Psychotic disorder—Hyoscyamine—pancreatitis	0.0136	0.0247	CcSEcCtD
Amphetamine—Anaphylactic shock—Propantheline—pancreatitis	0.0134	0.0242	CcSEcCtD
Amphetamine—Irritability—Hyoscyamine—pancreatitis	0.0133	0.0241	CcSEcCtD
Amphetamine—Tachycardia—Propantheline—pancreatitis	0.0131	0.0237	CcSEcCtD
Amphetamine—Aspartame—TRPV1—pancreatitis	0.013	0.487	CrCbGaD
Amphetamine—Insomnia—Propantheline—pancreatitis	0.0121	0.0219	CcSEcCtD
Amphetamine—Somnolence—Propantheline—pancreatitis	0.0119	0.0215	CcSEcCtD
Amphetamine—Constipation—Propantheline—pancreatitis	0.0114	0.0207	CcSEcCtD
Amphetamine—Erectile dysfunction—Hyoscyamine—pancreatitis	0.0111	0.0201	CcSEcCtD
Amphetamine—Depression—Hyoscyamine—pancreatitis	0.0107	0.0194	CcSEcCtD
Amphetamine—Urticaria—Propantheline—pancreatitis	0.0106	0.0193	CcSEcCtD
Amphetamine—Acute coronary syndrome—Hyoscyamine—pancreatitis	0.0106	0.0192	CcSEcCtD
Amphetamine—Myocardial infarction—Hyoscyamine—pancreatitis	0.0105	0.0191	CcSEcCtD
Amphetamine—Sweating—Hyoscyamine—pancreatitis	0.0103	0.0187	CcSEcCtD
Amphetamine—Hypersensitivity—Propantheline—pancreatitis	0.00986	0.0179	CcSEcCtD
Amphetamine—Asthenia—Propantheline—pancreatitis	0.0096	0.0174	CcSEcCtD
Amphetamine—Dizziness—Propantheline—pancreatitis	0.00885	0.016	CcSEcCtD
Amphetamine—Vomiting—Propantheline—pancreatitis	0.00851	0.0154	CcSEcCtD
Amphetamine—Rash—Propantheline—pancreatitis	0.00844	0.0153	CcSEcCtD
Amphetamine—Dermatitis—Propantheline—pancreatitis	0.00843	0.0153	CcSEcCtD
Amphetamine—Headache—Propantheline—pancreatitis	0.00839	0.0152	CcSEcCtD
Amphetamine—Tension—Hyoscyamine—pancreatitis	0.00824	0.0149	CcSEcCtD
Amphetamine—Nervousness—Hyoscyamine—pancreatitis	0.00815	0.0148	CcSEcCtD
Amphetamine—Nausea—Propantheline—pancreatitis	0.00795	0.0144	CcSEcCtD
Amphetamine—Agitation—Hyoscyamine—pancreatitis	0.00772	0.014	CcSEcCtD
Amphetamine—Angioedema—Hyoscyamine—pancreatitis	0.00767	0.0139	CcSEcCtD
Amphetamine—Palpitations—Hyoscyamine—pancreatitis	0.00742	0.0134	CcSEcCtD
Amphetamine—Benzyl alcohol—ALDH2—pancreatitis	0.00735	0.276	CrCbGaD
Amphetamine—Convulsion—Hyoscyamine—pancreatitis	0.00727	0.0132	CcSEcCtD
Amphetamine—Chest pain—Hyoscyamine—pancreatitis	0.00715	0.0129	CcSEcCtD
Amphetamine—Anxiety—Hyoscyamine—pancreatitis	0.00712	0.0129	CcSEcCtD
Amphetamine—Dry mouth—Hyoscyamine—pancreatitis	0.00699	0.0127	CcSEcCtD
Amphetamine—Anaphylactic shock—Hyoscyamine—pancreatitis	0.00685	0.0124	CcSEcCtD
Amphetamine—Tachycardia—Hyoscyamine—pancreatitis	0.00669	0.0121	CcSEcCtD
Amphetamine—Hyperhidrosis—Hyoscyamine—pancreatitis	0.00662	0.012	CcSEcCtD
Amphetamine—Insomnia—Hyoscyamine—pancreatitis	0.0062	0.0112	CcSEcCtD
Amphetamine—Dyspnoea—Hyoscyamine—pancreatitis	0.00611	0.0111	CcSEcCtD
Amphetamine—Somnolence—Hyoscyamine—pancreatitis	0.00609	0.011	CcSEcCtD
Amphetamine—Dyspepsia—Hyoscyamine—pancreatitis	0.00603	0.0109	CcSEcCtD
Amphetamine—Fatigue—Hyoscyamine—pancreatitis	0.00591	0.0107	CcSEcCtD
Amphetamine—Constipation—Hyoscyamine—pancreatitis	0.00586	0.0106	CcSEcCtD
Amphetamine—Gastrointestinal pain—Hyoscyamine—pancreatitis	0.0056	0.0101	CcSEcCtD
Amphetamine—Urticaria—Hyoscyamine—pancreatitis	0.00544	0.00986	CcSEcCtD
Amphetamine—Abdominal pain—Hyoscyamine—pancreatitis	0.00542	0.00981	CcSEcCtD
Amphetamine—Body temperature increased—Hyoscyamine—pancreatitis	0.00542	0.00981	CcSEcCtD
Amphetamine—Hypersensitivity—Hyoscyamine—pancreatitis	0.00505	0.00914	CcSEcCtD
Amphetamine—Asthenia—Hyoscyamine—pancreatitis	0.00492	0.0089	CcSEcCtD
Amphetamine—Diarrhoea—Hyoscyamine—pancreatitis	0.00469	0.00849	CcSEcCtD
Amphetamine—Dizziness—Hyoscyamine—pancreatitis	0.00453	0.00821	CcSEcCtD
Amphetamine—Vomiting—Hyoscyamine—pancreatitis	0.00436	0.00789	CcSEcCtD
Amphetamine—Rash—Hyoscyamine—pancreatitis	0.00432	0.00782	CcSEcCtD
Amphetamine—Dermatitis—Hyoscyamine—pancreatitis	0.00432	0.00782	CcSEcCtD
Amphetamine—Headache—Hyoscyamine—pancreatitis	0.00429	0.00777	CcSEcCtD
Amphetamine—Nausea—Hyoscyamine—pancreatitis	0.00407	0.00737	CcSEcCtD
Amphetamine—Pseudoephedrine—TNF—pancreatitis	0.0027	0.101	CrCbGaD
Amphetamine—Nateglinide—PPARG—pancreatitis	0.00265	0.0993	CrCbGaD
Amphetamine—Nateglinide—ALB—pancreatitis	0.000996	0.0374	CrCbGaD
Amphetamine—DRD2—Circadian rythm related genes—EGR1—pancreatitis	0.000557	0.00132	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—FDX1—pancreatitis	0.000543	0.00129	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCL5—pancreatitis	0.000542	0.00129	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—PPARG—pancreatitis	0.000538	0.00128	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—BDKRB2—pancreatitis	0.000535	0.00127	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PNLIP—pancreatitis	0.000532	0.00126	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PRSS3—pancreatitis	0.000532	0.00126	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGA—pancreatitis	0.000527	0.00125	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—HTR2A—pancreatitis	0.000526	0.00125	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CNR1—pancreatitis	0.000525	0.00125	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—TRPV1—pancreatitis	0.000515	0.00122	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH4—pancreatitis	0.000505	0.0012	CbGpPWpGaD
Amphetamine—SLC18A2—SLC-mediated transmembrane transport—ALB—pancreatitis	0.000503	0.0012	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—pancreatitis	0.000503	0.00119	CbGpPWpGaD
Amphetamine—CYP2D6—Biological oxidations—ALDH2—pancreatitis	0.000501	0.00119	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—BDKRB2—pancreatitis	0.000496	0.00118	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SMO—pancreatitis	0.00049	0.00116	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PTHLH—pancreatitis	0.00049	0.00116	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—CNR1—pancreatitis	0.000487	0.00116	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—KNG1—pancreatitis	0.000487	0.00116	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL1B—pancreatitis	0.000482	0.00115	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—CASP3—pancreatitis	0.000481	0.00114	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—FGB—pancreatitis	0.000479	0.00114	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HTR2A—pancreatitis	0.000478	0.00114	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—XDH—pancreatitis	0.000477	0.00113	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—SCT—pancreatitis	0.000477	0.00113	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CASR—pancreatitis	0.000477	0.00113	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PRSS1—pancreatitis	0.000475	0.00113	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CX3CL1—pancreatitis	0.000467	0.00111	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PPP3CA—pancreatitis	0.000467	0.00111	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCK—pancreatitis	0.000455	0.00108	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—MTNR1B—pancreatitis	0.000455	0.00108	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—SST—pancreatitis	0.000452	0.00107	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PRSS3—pancreatitis	0.00045	0.00107	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PNLIP—pancreatitis	0.00045	0.00107	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SST—pancreatitis	0.000448	0.00106	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ADH1B—pancreatitis	0.000445	0.00106	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—DUSP6—pancreatitis	0.000444	0.00105	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR2—pancreatitis	0.000443	0.00105	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—TACR1—pancreatitis	0.000443	0.00105	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCKAR—pancreatitis	0.000436	0.00103	CbGpPWpGaD
Amphetamine—SLC22A3—SLC-mediated transmembrane transport—ALB—pancreatitis	0.000435	0.00103	CbGpPWpGaD
Amphetamine—SLC22A5—SLC-mediated transmembrane transport—ALB—pancreatitis	0.000434	0.00103	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—MDM2—pancreatitis	0.000432	0.00103	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—pancreatitis	0.000425	0.00101	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—BDKRB2—pancreatitis	0.000421	0.001	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CNR1—pancreatitis	0.000418	0.000992	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CNR1—pancreatitis	0.000413	0.000981	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CCL5—pancreatitis	0.000407	0.000967	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—XDH—pancreatitis	0.000404	0.000959	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—GCG—pancreatitis	0.000399	0.000948	CbGpPWpGaD
Amphetamine—SLC6A4—NRF2 pathway—TGFB1—pancreatitis	0.000395	0.000939	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—KNG1—pancreatitis	0.000387	0.000919	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KNG1—pancreatitis	0.000383	0.00091	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—LEP—pancreatitis	0.000378	0.000898	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—SMO—pancreatitis	0.000377	0.000895	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—PTHLH—pancreatitis	0.000377	0.000895	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ADH1B—pancreatitis	0.000377	0.000895	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CCL2—pancreatitis	0.000374	0.000887	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—CTRB2—pancreatitis	0.000361	0.000857	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PLA2G1B—pancreatitis	0.000355	0.000843	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—PDGFA—pancreatitis	0.000352	0.000837	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—TNF—pancreatitis	0.00035	0.000831	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PPY—pancreatitis	0.000348	0.000828	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—SST—pancreatitis	0.000345	0.000818	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—A2M—pancreatitis	0.000343	0.000814	CbGpPWpGaD
Amphetamine—SLC6A2—NRF2 pathway—TGFB1—pancreatitis	0.00034	0.000807	CbGpPWpGaD
Amphetamine—SLC6A2—SLC-mediated transmembrane transport—ALB—pancreatitis	0.000339	0.000804	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—MDM2—pancreatitis	0.000336	0.000798	CbGpPWpGaD
Amphetamine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—pancreatitis	0.000333	0.000791	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—PPARG—pancreatitis	0.000329	0.000782	CbGpPWpGaD
Amphetamine—TAAR1—GPCR downstream signaling—CXCL8—pancreatitis	0.000325	0.000772	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—BDKRB2—pancreatitis	0.000324	0.000769	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL5—pancreatitis	0.000324	0.000768	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL5—pancreatitis	0.00032	0.000761	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CNR1—pancreatitis	0.000318	0.000755	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PPY—pancreatitis	0.000316	0.000751	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALDH2—pancreatitis	0.000314	0.000745	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LPL—pancreatitis	0.000313	0.000744	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—FDX1—pancreatitis	0.000313	0.000743	CbGpPWpGaD
Amphetamine—SLC18A2—Transmission across Chemical Synapses—HRAS—pancreatitis	0.000309	0.000734	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—GCG—pancreatitis	0.000307	0.000729	CbGpPWpGaD
Amphetamine—SLC6A3—NRF2 pathway—TGFB1—pancreatitis	0.000301	0.000715	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PLA2G1B—pancreatitis	0.0003	0.000713	CbGpPWpGaD
Amphetamine—SLC6A3—SLC-mediated transmembrane transport—ALB—pancreatitis	0.0003	0.000713	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—SPP1—pancreatitis	0.000297	0.000704	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—CXCL8—pancreatitis	0.000295	0.000701	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—KNG1—pancreatitis	0.000295	0.0007	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH4—pancreatitis	0.000291	0.000691	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—A2M—pancreatitis	0.00029	0.000689	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—pancreatitis	0.000285	0.000678	CbGpPWpGaD
Amphetamine—SLC6A4—SIDS Susceptibility Pathways—IL6—pancreatitis	0.000283	0.000671	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HTR2A—pancreatitis	0.000282	0.000671	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRSS1—pancreatitis	0.000273	0.000649	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SCT—pancreatitis	0.000269	0.00064	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CASR—pancreatitis	0.000269	0.00064	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALDH2—pancreatitis	0.000265	0.00063	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—LEP—pancreatitis	0.000263	0.000623	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PNLIP—pancreatitis	0.000259	0.000616	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PRSS3—pancreatitis	0.000259	0.000616	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—MDM2—pancreatitis	0.000257	0.000611	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—MTNR1B—pancreatitis	0.000257	0.00061	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCK—pancreatitis	0.000257	0.00061	CbGpPWpGaD
Amphetamine—SLC18A2—Transmembrane transport of small molecules—ALB—pancreatitis	0.000256	0.000607	CbGpPWpGaD
Amphetamine—CYP2A6—NRF2 pathway—TGFB1—pancreatitis	0.000252	0.000597	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR2—pancreatitis	0.00025	0.000595	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—TACR1—pancreatitis	0.00025	0.000595	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL5—pancreatitis	0.000246	0.000585	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCKAR—pancreatitis	0.000246	0.000585	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SCT—pancreatitis	0.000245	0.000581	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CASR—pancreatitis	0.000245	0.000581	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CX3CL1—pancreatitis	0.00024	0.00057	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—GCG—pancreatitis	0.000238	0.000565	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—NRAS—pancreatitis	0.000237	0.000563	CbGpPWpGaD
Amphetamine—SLC18A2—Neuronal System—HRAS—pancreatitis	0.000237	0.000563	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—MTNR1B—pancreatitis	0.000233	0.000554	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCK—pancreatitis	0.000233	0.000554	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—XDH—pancreatitis	0.000233	0.000552	CbGpPWpGaD
Amphetamine—SLC6A4—Circadian rythm related genes—IL6—pancreatitis	0.000231	0.000548	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR2—pancreatitis	0.000227	0.00054	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—TACR1—pancreatitis	0.000227	0.00054	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—INS—pancreatitis	0.000224	0.000533	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCKAR—pancreatitis	0.000224	0.000531	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CCL2—pancreatitis	0.000223	0.000529	CbGpPWpGaD
Amphetamine—DRD2—G alpha (i) signalling events—CXCL8—pancreatitis	0.000222	0.000526	CbGpPWpGaD
Amphetamine—SLC22A3—Transmembrane transport of small molecules—ALB—pancreatitis	0.000221	0.000525	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CCL2—pancreatitis	0.000221	0.000524	CbGpPWpGaD
Amphetamine—SLC22A5—Transmembrane transport of small molecules—ALB—pancreatitis	0.00022	0.000524	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—HTR2A—pancreatitis	0.000217	0.000516	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ADH1B—pancreatitis	0.000217	0.000515	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—PTHLH—pancreatitis	0.000213	0.000506	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PNLIP—pancreatitis	0.000208	0.000495	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—KRAS—pancreatitis	0.000204	0.000484	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—CTRB2—pancreatitis	0.000202	0.000481	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—GCG—pancreatitis	0.000201	0.000478	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—SST—pancreatitis	0.000195	0.000462	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SMO—pancreatitis	0.000193	0.000459	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PTHLH—pancreatitis	0.000193	0.000459	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPY—pancreatitis	0.000187	0.000444	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—MDM2—pancreatitis	0.000187	0.000443	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—LPL—pancreatitis	0.000187	0.000443	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—PPP3CA—pancreatitis	0.000184	0.000438	CbGpPWpGaD
Amphetamine—SLC6A3—Transmission across Chemical Synapses—HRAS—pancreatitis	0.000184	0.000438	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—BDKRB2—pancreatitis	0.000183	0.000435	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CNR1—pancreatitis	0.00018	0.000427	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—SST—pancreatitis	0.000177	0.00042	CbGpPWpGaD
Amphetamine—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatitis	0.000176	0.000419	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—FDX1—pancreatitis	0.000175	0.000417	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CXCL8—pancreatitis	0.000174	0.000414	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—GCG—pancreatitis	0.000174	0.000412	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—HRAS—pancreatitis	0.000173	0.000412	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PLA2G1B—pancreatitis	0.000173	0.000411	CbGpPWpGaD
Amphetamine—SLC6A2—Transmembrane transport of small molecules—ALB—pancreatitis	0.000172	0.000409	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CCL2—pancreatitis	0.00017	0.000403	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—A2M—pancreatitis	0.000167	0.000397	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—CASP3—pancreatitis	0.000167	0.000397	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—KNG1—pancreatitis	0.000167	0.000395	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—BDKRB2—pancreatitis	0.000166	0.000395	CbGpPWpGaD
Amphetamine—TAAR1—Signaling by GPCR—IL6—pancreatitis	0.000166	0.000394	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CNR1—pancreatitis	0.000163	0.000387	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH4—pancreatitis	0.000163	0.000387	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—LPL—pancreatitis	0.000158	0.000375	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—GCG—pancreatitis	0.000158	0.000374	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRSS1—pancreatitis	0.000153	0.000364	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALDH2—pancreatitis	0.000153	0.000363	CbGpPWpGaD
Amphetamine—SLC6A3—Transmembrane transport of small molecules—ALB—pancreatitis	0.000152	0.000362	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KNG1—pancreatitis	0.000151	0.000359	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PRSS3—pancreatitis	0.000145	0.000345	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PNLIP—pancreatitis	0.000145	0.000345	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SCT—pancreatitis	0.000144	0.000343	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASR—pancreatitis	0.000144	0.000343	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGG—pancreatitis	0.000144	0.000343	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CX3CL1—pancreatitis	0.000142	0.000336	CbGpPWpGaD
Amphetamine—SLC6A3—Neuronal System—HRAS—pancreatitis	0.000141	0.000335	CbGpPWpGaD
Amphetamine—DRD2—Circadian rythm related genes—IL6—pancreatitis	0.000141	0.000335	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—NRAS—pancreatitis	0.00014	0.000332	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CCL5—pancreatitis	0.000139	0.000331	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCK—pancreatitis	0.000138	0.000327	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MTNR1B—pancreatitis	0.000138	0.000327	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PPARG—pancreatitis	0.000136	0.000323	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—A2M—pancreatitis	0.000134	0.000319	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR2—pancreatitis	0.000134	0.000319	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TACR1—pancreatitis	0.000134	0.000319	CbGpPWpGaD
Amphetamine—DRD2—GPCR ligand binding—CXCL8—pancreatitis	0.000134	0.000319	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—INS—pancreatitis	0.000134	0.000317	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCKAR—pancreatitis	0.000132	0.000314	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—XDH—pancreatitis	0.00013	0.00031	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—TGFB1—pancreatitis	0.00013	0.000309	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL5—pancreatitis	0.000126	0.0003	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGA—pancreatitis	0.000123	0.000292	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—HTR2A—pancreatitis	0.000123	0.000292	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—ALB—pancreatitis	0.000122	0.000291	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ADH1B—pancreatitis	0.000122	0.000289	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—KRAS—pancreatitis	0.00012	0.000286	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—GCG—pancreatitis	0.000116	0.000275	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PPARG—pancreatitis	0.000115	0.000274	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PTHLH—pancreatitis	0.000114	0.000271	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SMO—pancreatitis	0.000114	0.000271	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—INS—pancreatitis	0.000113	0.000268	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—FGB—pancreatitis	0.000112	0.000265	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HTR2A—pancreatitis	0.000111	0.000265	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PPP3CA—pancreatitis	0.000109	0.000259	CbGpPWpGaD
Amphetamine—MAOB—Metabolism—PTGS2—pancreatitis	0.000107	0.000254	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SST—pancreatitis	0.000104	0.000248	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—ALB—pancreatitis	0.000104	0.000246	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—DUSP6—pancreatitis	0.000104	0.000246	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—HRAS—pancreatitis	0.000102	0.000243	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—BDKRB2—pancreatitis	9.82e-05	0.000233	CbGpPWpGaD
Amphetamine—TAAR1—Signaling Pathways—IL6—pancreatitis	9.8e-05	0.000233	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PLA2G1B—pancreatitis	9.7e-05	0.00023	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CNR1—pancreatitis	9.64e-05	0.000229	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—A2M—pancreatitis	9.37e-05	0.000222	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—GCG—pancreatitis	9.31e-05	0.000221	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—LPL—pancreatitis	9.09e-05	0.000216	CbGpPWpGaD
Amphetamine—SLC22A3—Metabolism—PTGS2—pancreatitis	9.06e-05	0.000215	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KNG1—pancreatitis	8.93e-05	0.000212	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CCL2—pancreatitis	8.71e-05	0.000207	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALDH2—pancreatitis	8.57e-05	0.000203	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—PDGFA—pancreatitis	8.22e-05	0.000195	CbGpPWpGaD
Amphetamine—DRD2—GPCR downstream signaling—CXCL8—pancreatitis	7.59e-05	0.00018	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL5—pancreatitis	7.47e-05	0.000177	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LPL—pancreatitis	7.3e-05	0.000173	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—SPP1—pancreatitis	6.92e-05	0.000164	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—CXCL8—pancreatitis	6.89e-05	0.000164	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PPARG—pancreatitis	6.63e-05	0.000158	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HTR2A—pancreatitis	6.59e-05	0.000156	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—INS—pancreatitis	6.51e-05	0.000155	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—GCG—pancreatitis	6.49e-05	0.000154	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—LEP—pancreatitis	6.12e-05	0.000145	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—ALB—pancreatitis	5.97e-05	0.000142	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—NRAS—pancreatitis	5.53e-05	0.000131	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—INS—pancreatitis	5.23e-05	0.000124	CbGpPWpGaD
Amphetamine—CYP2A6—Metabolism—PTGS2—pancreatitis	5.22e-05	0.000124	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CCL2—pancreatitis	5.15e-05	0.000122	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—LPL—pancreatitis	5.1e-05	0.000121	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—KRAS—pancreatitis	4.76e-05	0.000113	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—MDM2—pancreatitis	4.35e-05	0.000103	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CXCL8—pancreatitis	4.07e-05	9.66e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—HRAS—pancreatitis	4.04e-05	9.6e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—CASP3—pancreatitis	3.89e-05	9.25e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling by GPCR—IL6—pancreatitis	3.87e-05	9.19e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PPARG—pancreatitis	3.72e-05	8.84e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—INS—pancreatitis	3.65e-05	8.67e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—ALB—pancreatitis	3.35e-05	7.94e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—NRAS—pancreatitis	3.26e-05	7.75e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—TGFB1—pancreatitis	3.03e-05	7.2e-05	CbGpPWpGaD
Amphetamine—CYP2D6—Metabolism—PTGS2—pancreatitis	2.93e-05	6.95e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—KRAS—pancreatitis	2.81e-05	6.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—HRAS—pancreatitis	2.39e-05	5.67e-05	CbGpPWpGaD
Amphetamine—DRD2—Signaling Pathways—IL6—pancreatitis	2.29e-05	5.43e-05	CbGpPWpGaD
